$VRAL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VG Life Sciences Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VG Life Sciences Inc.. Get notifications about new insider transactions in VG Life Sciences Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 01 2007 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO | Sell | J | 0.06 | 2,400,000 | 150,000 | 17,605,302 | 20 M to 17.6 M (-12.00 %) |
Jun 29 2007 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | A | 0.25 | 1,800,000 | 450,000 | 6,600,000 | |
Jun 29 2007 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | A | 0.20 | 1,800,000 | 360,000 | 6,600,000 | |
Jun 29 2007 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | A | 0.20 | 2,300,000 | 460,000 | 6,600,000 | |
Jun 29 2007 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | D | 0.45 | 1,800,000 | 810,000 | 6,600,000 | |
Jun 29 2007 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | D | 0.52 | 2,300,000 | 1,196,000 | 6,600,000 | |
Jun 29 2007 | VRAL | VG Life Sciences I ... | KARAGEOZIAN HAMPAR | Director | Option Exercise | A | 0.52 | 2,300,000 | 1,196,000 | 2,300,000 | |
Jun 28 2007 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | A | 0.08 | 2,500,000 | 200,000 | 6,600,000 | |
Mar 09 2007 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | S | 0.40 | 700,000 | 280,000 | 9,157,441 | |
Mar 09 2007 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | O | 0.40 | 482,772 | 193,109 | 9,374,669 | |
Mar 09 2007 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Sell | J | 0.08 | 808,213 | 64,657 | 19,714,317 | 20.5 M to 19.7 M (-3.94 %) |
Mar 09 2007 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Sell | J | 0.05 | 1,000,000 | 50,000 | 19,522,530 | 20.5 M to 19.5 M (-4.87 %) |
Mar 09 2007 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Buy | O | 0.40 | 482,772 | 193,109 | 21,005,302 | 20.5 M to 21 M (+2.35 %) |
Dec 19 2006 | VRAL | VG Life Sciences I ... | KARAGEOZIAN HAMPAR | Director | Gift | G | 0.00 | 1,000,000 | 0 | 9,276,221 | 10.3 M to 9.3 M (-9.73 %) |
Sep 12 2006 | VRAL | VG Life Sciences I ... | Ord Monica Denise | Sr. VP Comm. & Corp ... | Buy | S | 0.16 | 300,000 | 47,100 | 1,715,000 | 1.4 M to 1.7 M (+21.20 %) |
Dec 06 2005 | VRAL | VG Life Sciences I ... | Lefebvre John D | 10% Owner | Option Exercise | P | 0.45 | 2,000,000 | 900,000 | 2,000,000 | |
Dec 06 2005 | VRAL | VG Life Sciences I ... | Lefebvre John D | 10% Owner | Option Exercise | P | 0.60 | 4,000,000 | 2,400,000 | 4,000,000 | |
Dec 06 2005 | VRAL | VG Life Sciences I ... | Lefebvre John D | 10% Owner | Option Exercise | H | 1.00 | 4,000,000 | 4,000,000 | 0 | |
Dec 06 2005 | VRAL | VG Life Sciences I ... | Lefebvre John D | 10% Owner | Buy | P | 0.25 | 2,000,000 | 500,000 | 10,000,000 | 8 M to 10 M (+25.00 %) |
Oct 20 2005 | VRAL | VG Life Sciences I ... | Ord Monica Denise | SVP, Corp Dev & Com ... | Option Exercise | A | 0.01 | 110,000 | 1,100 | 110,000 | |
Aug 02 2005 | VRAL | VG Life Sciences I ... | ZHABILOV HARRY | EVP Research & Deve ... | Buy | J | 0.00 | 2,500,000 | 0 | 10,393,679 | 7.9 M to 10.4 M (+31.67 %) |
Oct 22 2004 | VRAL | VG Life Sciences I ... | KARAGEOZIAN HAMPAR | Director | Option Exercise | A | 0.58 | 49,929 | 28,959 | 49,929 | |
Oct 22 2004 | VRAL | VG Life Sciences I ... | KARAGEOZIAN HAMPAR | Director | Option Exercise | A | 0.65 | 49,929 | 32,454 | 49,929 | |
Oct 22 2004 | VRAL | VG Life Sciences I ... | KARAGEOZIAN HAMPAR | Director | Option Exercise | A | 0.38 | 49,929 | 18,973 | 49,929 | |
Oct 22 2004 | VRAL | VG Life Sciences I ... | KARAGEOZIAN HAMPAR | Director | Option Exercise | A | 0.52 | 99,858 | 51,926 | 99,858 | |
Oct 22 2004 | VRAL | VG Life Sciences I ... | KARAGEOZIAN HAMPAR | Director | Option Exercise | A | 0.40 | 4,934,712 | 1,973,885 | 4,934,712 | |
Oct 22 2004 | VRAL | VG Life Sciences I ... | KARAGEOZIAN HAMPAR | Director | Grant | A | 0.00 | 4,934,712 | 0 | 10,276,221 | 5.3 M to 10.3 M (+92.38 %) |
Oct 22 2004 | VRAL | VG Life Sciences I ... | KARAGEOZIAN HAMPAR | Director | Gift | G | 0.00 | 100,000 | 0 | 10,276,221 | 10.4 M to 10.3 M (-0.96 %) |
Oct 22 2004 | VRAL | VG Life Sciences I ... | ZHABILOV HARRY | Exec. VP | Option Exercise | A | 0.58 | 49,854 | 28,915 | 49,854 | |
Oct 22 2004 | VRAL | VG Life Sciences I ... | ZHABILOV HARRY | Exec. VP | Option Exercise | A | 0.65 | 49,854 | 32,405 | 49,854 | |
Oct 22 2004 | VRAL | VG Life Sciences I ... | ZHABILOV HARRY | Exec. VP | Option Exercise | A | 0.38 | 49,854 | 18,945 | 49,854 | |
Oct 22 2004 | VRAL | VG Life Sciences I ... | ZHABILOV HARRY | Exec. VP | Option Exercise | A | 0.52 | 99,708 | 51,848 | 99,708 | |
Oct 22 2004 | VRAL | VG Life Sciences I ... | ZHABILOV HARRY | Exec. VP | Option Exercise | A | 0.45 | 1,800,000 | 810,000 | 4,100,000 | |
Oct 22 2004 | VRAL | VG Life Sciences I ... | ZHABILOV HARRY | Exec. VP | Option Exercise | A | 0.40 | 4,927,299 | 1,970,920 | 4,927,299 | |
Oct 22 2004 | VRAL | VG Life Sciences I ... | ZHABILOV HARRY | Exec. VP | Grant | A | 0.00 | 4,927,299 | 0 | 7,893,679 | 3 M to 7.9 M (+166.10 %) |
Oct 22 2004 | VRAL | VG Life Sciences I ... | ZHABILOV HARRY | Exec. VP | Buy | J | 0.00 | 2,966,380 | 0 | 7,893,679 | 4.9 M to 7.9 M (+60.20 %) |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.40 | 9,884 | 3,954 | 9,857,441 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.40 | 1,850,466 | 740,186 | 9,857,411 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.40 | 1,817,521 | 727,008 | 9,857,441 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.40 | 4,986,600 | 1,994,640 | 9,857,441 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | A | 0.40 | 1,192,970 | 477,188 | 9,857,441 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.58 | 100 | 58 | 99,737 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.58 | 18,723 | 10,859 | 99,737 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.58 | 18,390 | 10,666 | 99,737 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.58 | 50,454 | 29,263 | 99,737 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | A | 0.58 | 12,070 | 7,001 | 99,737 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.65 | 100 | 65 | 99,737 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.65 | 18,723 | 12,170 | 99,737 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.65 | 18,390 | 11,954 | 99,737 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.65 | 50,454 | 32,795 | 99,737 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | A | 0.65 | 12,070 | 7,846 | 99,737 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.38 | 100 | 38 | 99,737 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.38 | 18,723 | 7,115 | 99,737 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.38 | 18,390 | 6,988 | 99,737 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.38 | 50,454 | 19,173 | 90,737 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | A | 0.38 | 12,070 | 4,587 | 99,737 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.52 | 200 | 104 | 199,473 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.52 | 37,446 | 19,472 | 199,473 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.52 | 36,779 | 19,125 | 199,473 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.52 | 100,908 | 52,472 | 199,473 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | A | 0.52 | 24,140 | 12,553 | 199,473 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | J | 0.40 | 4,725,708 | 1,890,283 | 4,725,708 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Option Exercise | A | 0.45 | 1,800,000 | 810,000 | 4,100,000 | |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Buy | J | 0.00 | 9,884 | 0 | 20,510,630 | 20.5 M to 20.5 M (+0.05 %) |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Buy | J | 0.00 | 1,850,466 | 0 | 20,510,630 | 18.7 M to 20.5 M (+9.92 %) |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Buy | J | 0.00 | 1,817,521 | 0 | 20,510,630 | 18.7 M to 20.5 M (+9.72 %) |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Buy | J | 0.00 | 4,986,600 | 0 | 20,510,630 | 15.5 M to 20.5 M (+32.12 %) |
Oct 21 2004 | VRAL | VG Life Sciences I ... | KELEDJIAN HAIG | CEO and President | Grant | A | 0.00 | 1,192,970 | 0 | 20,510,630 | 19.3 M to 20.5 M (+6.18 %) |
May 20 2004 | VRAL | VG Life Sciences I ... | THERAPEUTIC GENETICS INC | 10% Owner | Option Exercise | A | 0.58 | 250,000 | 145,000 | 1,250,000 | |
May 20 2004 | VRAL | VG Life Sciences I ... | THERAPEUTIC GENETICS INC | 10% Owner | Option Exercise | A | 0.65 | 250,000 | 162,500 | 1,250,000 | |
May 20 2004 | VRAL | VG Life Sciences I ... | THERAPEUTIC GENETICS INC | 10% Owner | Option Exercise | A | 0.38 | 250,000 | 95,000 | 1,250,000 | |
Feb 24 2004 | VRAL | VG Life Sciences I ... | KARAGEOZIAN HAMPAR | COO | Gift | G | 0.00 | 500,000 | 0 | 5,441,509 | 5.9 M to 5.4 M (-8.42 %) |
Feb 23 2004 | VRAL | VG Life Sciences I ... | WRIGHT TIMOTHY W III | Director | Option Exercise | A | 0.01 | 100,000 | 1,000 | 200,000 | |
Feb 23 2004 | VRAL | VG Life Sciences I ... | WRIGHT TIMOTHY W III | Director | Option Exercise | A | 0.01 | 100,000 | 1,000 | 100,000 | |
Feb 23 2004 | VRAL | VG Life Sciences I ... | WRIGHT TIMOTHY W III | Director | Buy | J | 0.00 | 250,000 | 0 | 350,000 | 100 K to 350 K (+250.00 %) |
Feb 23 2004 | VRAL | VG Life Sciences I ... | WRIGHT TIMOTHY W III | Director | Option Exercise | A | 0.01 | 100,000 | 1,000 | 200,000 | |
Feb 23 2004 | VRAL | VG Life Sciences I ... | WRIGHT TIMOTHY W III | Director | Option Exercise | A | 0.01 | 100,000 | 1,000 | 100,000 | |
Feb 23 2004 | VRAL | VG Life Sciences I ... | WRIGHT TIMOTHY W III | Director | Buy | J | 0.00 | 250,000 | 0 | 350,000 | 100 K to 350 K (+250.00 %) |
Page: 1